Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Reform Proposals For Debate In 2000

Executive Summary

With Congress returning from recess Jan. 24, approaches to reforming Medicare will grow in importance as an election-year political issue. Announced reform proposals are listed below

You may also be interested in...



NACDS Rehires Coster To Head New Federal & State Programs Department

The National Association of Chain Drug Stores is adding a government relations consultant familiar with the association and with Medicare reform issues to its government affairs staff.

PhRMA Plan For Rx-Only Medicare Bill Calls For Independence From HCFA

The White House may be willing to support a Medicare drug benefit that is overseen by an agency other than the Health Care Financing Administration, Pharmaceutical Research & Manufacturers of America President Alan Holmer maintained.

NACDS Rehires Coster To Head New Federal & State Programs Department

The National Association of Chain Drug Stores is adding a government relations consultant familiar with the association and with Medicare reform issues to its government affairs staff.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS035488

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel